Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Airbus SE    AIR   NL0000235190

AIRBUS SE

(AIR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Airbus : and Koniku Inc. have made a significant step forward in the co-development of a solution for aircraft and ...

share with twitter share with LinkedIn share with facebook
05/04/2020 | 09:44am EDT

Airbus and Koniku Inc. embark on disruptive biotechnology solutions for aviation security operations

@Airbus @KonikuTech #innovation #biotech

Toulouse, 4 May 2020 - Airbus and Koniku Inc. have made a significant step forward in the co-development of a solution for aircraft and airport security operations, by extending research activities to include biological hazard detection capabilities, as well as chemical and explosive threats.

The disruptive biotechnology solution, which was originally focused on the contactless and automated detection, tracking and location of chemicals and explosives on-board aircraft and in airports, is now being adapted, in light of the COVID-19 crisis, to include the identification of biological hazards.

Based on the power of odor detection and quantification found in nature, the technical solution, developed to meet the rigorous operational regulatory requirements of aircraft and airport security operations, uses genetically engineered odorant receptors that produce an alarm signal when they come into contact with the molecular compounds of the hazard or threat that they have been programmed to detect.

Airbus and Koniku Inc. entered into a cooperation agreement in 2017, leveraging Airbus' expertise in sensor integration and knowledge of ground and on-board security operations within the aviation and defense industries as well as Koniku's biotechnology know-how for automated and scalable volatile organic compound detection (via their Konikore™ platform).

With in-situ testing planned for Q4 2020, Airbus is demonstrating, its ability to accelerate traditional research cycles in a real-time environment, in order to develop and bring to market

  1. game-changing,end-to-end, security solution at convincing scale and speed, thereby contributing to the continuous improvement of security in the air transport ecosystem, while increasing operational efficiency and improving passenger experience.
    • * *

About Airbus

Airbus is a global leader in aeronautics, space and related services. In 2019, it generated revenues of € 70 billion and employed a workforce of around 135,000. Airbus offers the most comprehensive range of passenger airliners. Airbus is also a European leader providing tanker, combat, transport and mission aircraft, as well as one of the world's leading space companies. In helicopters, Airbus provides the most efficient civil and military rotorcraft solutions worldwide.

Contacts for the media

Barton GREER

barton.greer@airbus.com

+1 (703)

334 1571

Matthieu DUVELLEROY

matthieu.duvelleroy@airbus.com

+33 (0)6 29 43 16 64

Lois BENQUET

lois.benquet@airbus.com

+33 (0)6

42 88 10 65

This and other press releases and high resolution photos are available on: AirbusMedia

Airbus Media Relations

Phone: +33 (0)5 61 93 10 00

2 rond-point Emile Dewoitine

Email: media@airbus.com

31700 Blagnac

Web: airbus.com

France

Follow us on Twitter: @airbus & @airbuspress

https://www.airbus.com/newsroom/

Page | 1

Disclaimer

Airbus SE published this content on 04 May 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 May 2020 13:43:08 UTC

share with twitter share with LinkedIn share with facebook
Latest news on AIRBUS SE
12:17aEnd of the runway for 747 jumbo as Boeing placed final part orders
RE
07/03Embraer union seeks planemaker's board ouster after failed Boeing deal
RE
07/03Air France and sister airline to cut 7,580 jobs
RE
07/03AIRBUS : Air France and HOP! airlines to cut 7,580 jobs
RE
07/03AIRBUS : Air France and HOP! airlines to cut 7,580 jobs
RE
07/03Air France and sister airline to cut 7,580 jobs
RE
07/03Rolls-Royce reviewing balance sheet options after COVID-19 hit
RE
07/03Rolls-Royce reviewing balance sheet options after COVID-19 hit
RE
07/03Namibia considering options for struggling national flag carrier -finance min..
RE
07/03AIRBUS : Could Save Jobs if French, German Governments Help, CEO Says -Spiegel
DJ
More news
Financials
Sales 2020 49 290 M 55 442 M 55 442 M
Net income 2020 2 062 M 2 319 M 2 319 M
Net cash 2020 904 M 1 017 M 1 017 M
P/E ratio 2020 24,3x
Yield 2020 0,57%
Capitalization 51 406 M 57 792 M 57 822 M
EV / Sales 2019
EV / Sales 2020 1,02x
Nbr of Employees 136 518
Free-Float 72,0%
Chart AIRBUS SE
Duration : Period :
Airbus SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AIRBUS SE
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 79,67 €
Last Close Price 65,63 €
Spread / Highest target 99,6%
Spread / Average Target 21,4%
Spread / Lowest Target -54,3%
EPS Revisions
Managers
NameTitle
Guillaume Faury Chief Executive Officer
René Richard Obermann Chairman
Michael Schöllhorn Chief Operating Officer
Dominik Asam Chief Financial Officer
Luc Hennekens Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
AIRBUS SE-49.70%57 792
BOEING COMPANY (THE)-44.50%102 036
DASSAULT AVIATION-28.89%7 776
TEXTRON-27.24%7 381
AVIC ELECTROMECHANICAL SYSTEMS CO.,LTD.17.58%4 141
AVICOPTER PLC-11.97%3 504